[go: up one dir, main page]

AR023369A1 - Secretagogos de la hormona del crecimiento - Google Patents

Secretagogos de la hormona del crecimiento

Info

Publication number
AR023369A1
AR023369A1 ARP000100708A ARP000100708A AR023369A1 AR 023369 A1 AR023369 A1 AR 023369A1 AR P000100708 A ARP000100708 A AR P000100708A AR P000100708 A ARP000100708 A AR P000100708A AR 023369 A1 AR023369 A1 AR 023369A1
Authority
AR
Argentina
Prior art keywords
growth
secretagogos
hormone
phenyl
alkyl
Prior art date
Application number
ARP000100708A
Other languages
English (en)
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of AR023369A1 publication Critical patent/AR023369A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06034—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Se describen secretagogos de la hormona del crecimiento y sus usos de la formula (1) en la que R1 es C6H5CH2OCH2-, C6H5(CH)3 o indol - ilmetilo; Y espirrolidinil-1-ilo, 4-alquil C1-6 piperidinil-1-ilo o NR2R2: R2 es independientemente un alquilo C1 a6; R3 es 2-naftilo o fenilo para sustituido con W; W esH, F, CF3, alcoxi C1-6 o fenilo y R4 es H o CH3 o una sal o solvato farmacéuticamente aceptable del mismo.
ARP000100708A 1999-02-19 2000-02-18 Secretagogos de la hormona del crecimiento AR023369A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US12081399P 1999-02-19 1999-02-19

Publications (1)

Publication Number Publication Date
AR023369A1 true AR023369A1 (es) 2002-09-04

Family

ID=22392709

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP000100708A AR023369A1 (es) 1999-02-19 2000-02-18 Secretagogos de la hormona del crecimiento

Country Status (13)

Country Link
EP (1) EP1153034B1 (es)
JP (1) JP2002539089A (es)
CN (1) CN1179972C (es)
AR (1) AR023369A1 (es)
AT (1) ATE375996T1 (es)
AU (1) AU765642B2 (es)
BR (1) BR0008321A (es)
CA (1) CA2362303A1 (es)
CO (1) CO5160260A1 (es)
DE (1) DE60036785D1 (es)
IL (1) IL144350A0 (es)
PE (1) PE20001468A1 (es)
WO (1) WO2000049037A1 (es)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6639076B1 (en) 1998-08-18 2003-10-28 Eli Lilly And Company Growth hormone secretagogues
US6828331B1 (en) 1999-02-19 2004-12-07 Eli Lilly And Company Growth hormone secretagogues
WO2001091752A1 (en) 2000-05-30 2001-12-06 Merck & Co., Inc. Melanocortin receptor agonists
US6756385B2 (en) * 2000-07-31 2004-06-29 Pfizer Inc. Imidazole derivatives
GT200100147A (es) * 2000-07-31 2002-06-25 Derivados de imidazol
WO2002032878A1 (en) * 2000-10-13 2002-04-25 Eli Lilly And Company Resolution process for preparation of substantially pure (r) and (s) enantiomers of 2-(4-nitroimidazolyl)-4-methoxyphenylpropionic acid and salts thereof
DE60111574T2 (de) 2001-01-23 2006-05-11 Gador S.A. Bisphosphonate enthaltende Zusammensetzungen zur Vorbeugung und/oder Heilung von metabolischen Knochenkrankheiten, Verfahren zu ihrer Herstellung und Benutzung dieser Zusammensetzungen
US7125840B2 (en) 2001-10-09 2006-10-24 Eli Lilly And Company Substituted dipeptides as growth hormone secretagogues
WO2003087069A2 (en) * 2002-04-09 2003-10-23 Eli Lilly And Company Dipeptidic growth hormone secretagogues
ATE399155T1 (de) 2004-03-23 2008-07-15 Pfizer Prod Inc Imidazolverbindungen zur behandlung von neurodegenerativen erkrankungen
EA200800659A1 (ru) 2005-09-22 2008-08-29 Пфайзер Продактс Инк. Соединения имидазола для лечения неврологических нарушений
US11884634B2 (en) 2019-08-09 2024-01-30 Pfizer Inc. Compositions of solid forms of (S)-2-(((S)-6,8-difluoro-1,2,3,4- tetrahydronaphthalen-2-yl)amino)-N-(1-(2-methyl-1-(neopentylamino)propan-2-yl)-1H-imidazol-4-yl)pentanamide
MA56748B1 (fr) 2019-08-09 2025-12-31 Pfizer Inc. Formes à l'état solide de (s)-2-(((s)-6,8-difluoro-1,2,3,4-tétrahydronaphthalén-2-yl)amino)-n-(1-(2-méthyl-1-(néopentylamino)propan-2-yl)-1h-imidazol-4-yl)pentanamide et utilisations assosiées
TWI905452B (zh) 2021-09-01 2025-11-21 美商斯普林渥克斯治療有限公司 尼羅司他（ｎｉｒｏｇａｃｅｓｔａｔ）之合成
US11504354B1 (en) 2021-09-08 2022-11-22 SpringWorks Therapeutics Inc.. Chlorinated tetralin compounds and pharmaceutical compositions

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL107836A (en) * 1992-12-11 1998-01-04 Merck & Co Inc Spiro piperidines and homologues, their preparation and pharmaceutical preparations containing them
HUT72076A (en) * 1992-12-11 1996-03-28 Merck & Co Inc Process for preparing spiro piperidines and homologs which promote release of growth hormone and pharmaceutical compositions containing them
US5721250A (en) * 1993-12-23 1998-02-24 Merck & Co. Inc. Di-and tri-substituted piperidines, pyrrolidines and hexahydro-1H-azepines promote release of growth hormone
JP2001502319A (ja) * 1996-10-15 2001-02-20 藤沢薬品工業株式会社 成長ホルモンの放出を促進するベンズオキセピン誘導体
ZA987385B (en) * 1997-08-19 2000-04-18 Lilly Co Eli Growth hormone secretagogues.
ZA987383B (en) * 1997-08-19 2000-02-17 Lilly Co Eli Treatment of congestive heart failure with growth hormone secretagogues.

Also Published As

Publication number Publication date
DE60036785D1 (de) 2007-11-29
PE20001468A1 (es) 2000-12-20
CO5160260A1 (es) 2002-05-30
CA2362303A1 (en) 2000-08-24
JP2002539089A (ja) 2002-11-19
CN1347420A (zh) 2002-05-01
EP1153034B1 (en) 2007-10-17
ATE375996T1 (de) 2007-11-15
BR0008321A (pt) 2002-01-29
WO2000049037A1 (en) 2000-08-24
EP1153034A1 (en) 2001-11-14
IL144350A0 (en) 2002-05-23
AU3496800A (en) 2000-09-04
CN1179972C (zh) 2004-12-15
AU765642B2 (en) 2003-09-25

Similar Documents

Publication Publication Date Title
AR023369A1 (es) Secretagogos de la hormona del crecimiento
ES2145922T3 (es) Compuestos espiro-azabiciclicos utiles en terapia.
CO4410179A1 (es) Compuestos de 1-fenil-3-dimetilamino-propano con efecto farmacologico
ATE282614T1 (de) Phenylharnstoff und phenylthioharnstoffderivate
AR048213A1 (es) 1-(4-mono-y di-halometilsulfonilfenil)-2-acilamino-fluorpropanoles analogos al florfenicol
ES2122570T3 (es) Inhibicion del crecimiento del pelo.
ES2078676T3 (es) Amidas de la glicilserina y composiciones cosmeticas, farmaceuticas o alimenticias que las contienen.
ATE77047T1 (de) Sebosuppressive topische zubereitungen.
ES488788A0 (es) Procedimiento de preparacion de una composicion farmaceuticaen particular psicotropa.
FI894061A0 (fi) Menetelmä lääkeaineina käyttökelpoisten , -disubstituoitujen N-sykloalkyylialkyylibentsyyliamiinien valmistamiseksi ja niiden synteesivälituotteita
UY28688A1 (es) Derivados de amida
AR025951A1 (es) Derivados de 4-hicroxibifenil hidrazidas y métodos para preparar los derivados.
FI812804L (fi) 2-(1,4-bensodioxan-2-ylalkyl)-imidazoler anvaendbara som antidepressiva laekemedel
NO177995C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive 1,3-dioksanderivater
ES2038216T3 (es) Procedimiento para la preparacion de 5-(3-alquil-5-t-butil-4-hidroxi-fenil)-2-amino-6h-1,3,4-tiadazinas y su empleo.
ES8801201A1 (es) Un procedimiento para preparar derivados de pirrolidona
ES2194709T3 (es) Procedimiento para preparar carbamatos de tetrahidrotiopiran-o-fluorados.
EP1056700A4 (en) MEDICAL APPLICATIONS OF PHENYL ALCOHOLS AND DERIVATIVES THEREOF
ES2088567T3 (es) Empleo de derivados de la 2-iminotioazolidin-4-ona como nuevos productos activos para medicamentos.
ES2038159T3 (es) Procedimiento para preparar derivados sustituidos de 2-aminoacetamida.
SE8008189L (sv) Foreningar med antiallergisk och antiulceros verkan, nemligen 1-oxo-1h-tiazolo(3,2-a)pyrimidin-2-karboxamider och mellanprodukter for dessa
AR004513A1 (es) Compuestos heterociclicos, metodo para prepararlos, uso de mismos para preparar medicamentos y composiciones farmaceuticas que los comprenden
ATE120188T1 (de) 15-deoxyprostaglandinderivat.
ECSP003355A (es) Seretagogos de la hormona del crecimiento
CO5040081A1 (es) Nuevos compuestos vidad farmaaceutica

Legal Events

Date Code Title Description
FB Suspension of granting procedure